KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
May 05, 2020 $35.11 $36.33 $34.69 $35.40 1 331 107
May 04, 2020 $31.89 $34.24 $31.72 $34.16 987 374
May 01, 2020 $33.55 $34.27 $31.50 $32.56 1 294 501
Apr 30, 2020 $36.18 $36.38 $34.40 $34.43 1 273 559
Apr 29, 2020 $38.34 $38.38 $36.36 $36.53 928 466
Apr 28, 2020 $40.00 $40.01 $37.15 $37.26 861 764
Apr 27, 2020 $39.21 $40.00 $38.92 $39.47 667 986
Apr 24, 2020 $38.95 $39.35 $37.70 $38.89 990 849
Apr 23, 2020 $36.85 $39.39 $36.85 $38.45 1 042 695
Apr 22, 2020 $37.94 $37.94 $36.08 $36.94 1 030 573
Apr 21, 2020 $37.72 $38.66 $36.17 $36.62 1 303 412
Apr 20, 2020 $35.72 $40.02 $35.72 $38.89 1 818 725
Apr 17, 2020 $35.98 $36.64 $35.09 $36.55 1 252 284
Apr 16, 2020 $35.07 $35.44 $33.05 $34.83 1 782 392
Apr 15, 2020 $36.86 $37.23 $34.41 $35.33 1 804 993
Apr 14, 2020 $35.90 $37.55 $35.10 $36.77 1 338 470
Apr 13, 2020 $35.65 $35.74 $33.68 $34.85 1 497 697
Apr 09, 2020 $32.25 $34.78 $32.17 $33.87 1 430 510
Apr 08, 2020 $30.25 $31.97 $29.61 $31.51 1 092 070
Apr 07, 2020 $29.15 $30.50 $28.65 $29.39 1 464 326
Apr 06, 2020 $27.22 $29.07 $26.75 $28.94 1 237 402
Apr 03, 2020 $26.50 $27.27 $25.84 $26.12 584 673
Apr 02, 2020 $26.22 $27.61 $25.79 $26.91 863 476
Apr 01, 2020 $28.03 $28.62 $26.19 $26.52 991 013
Mar 31, 2020 $29.16 $29.41 $27.60 $28.77 1 275 520
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT